Aerie Pharmaceuticals, an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, and DSM Biomedical, a global solutions provider in biomedical science and regenerative medicine, have expanded their collaborative research, development, and license agreement. In July 2017, Aerie entered into a research collaboration and license...